Breakthrough Treatments Targeting Severe Forms of the Disease Set to Transform Lives In a groundbreaking move, U.S. regulators have granted approval for two gene therapies designed to potentially cure sickle cell disease, a painful and hereditary blood disorder that disproportionately affects Black individuals in the United States. The Food and Drug Administration (FDA) announced on … Read more